Enecta is an Italian-Dutch company manufacturing and selling products derived from the processing of cannabis. The company is highly specialised in the extraction of the active ingredients from cannabis plant, mainly CBD, a non-psychoactive phytocannabinoid, and manufactures extracts, oils, capsules and crystals, which contain high concentrations of CBD. Founded in 2012 in the Netherlands by Italian entrepreneurs, the company works to innovate the research, the production and the uses of products containing phytocannabinoids. The company studies the applications related to the medical use for the pharmaceutical and nutraceutical industries. Enecta extracts fitocannabinoids in the form of extracts and 99% pure crystals from cannabis grown in Italy and Greece. The cultivation of raw material on certified fields without the use of pesticides or heavy metals, thoroughly follows the Guidelines on Good Agricultural and Collection Practice (GACP) which ensure high standards of safety and quality. The extraction takes place in GMP (Good Manufacturing Practices) and HACCP (Hazard Analysis and Critical Control Points) laboratories. Enecta, thanks to the work of its botanists, has also invested in the development of new genetics, to ensure high concentrations of different phytocannabinoids The company supports the research on medical cannabis and takes part as a partner and promoter in national and international medical and scientific conferences and events.